Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Presented for research literature review only Cocomazzi P et al
Outside of these conditions, GHK-Cu is generally well-tolerated, with minor injection site redness as the most common reported reaction
Research Overview Understanding the Triple-Receptor Mechanism Retatrutide is the first clinically advanced peptide engineered for balanced agonism at three class B G protein-coupled receptors simultaneously: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
Our clinical experience suggests optimal healing occurs within the 200-400 mcg range for most applications
Best for users wanting an oral option
